Oral Proteins and Peptides Market to Hit USD 20.36 Billion by 2029 with 22.5% CAGR | MarketsandMarkets™
The global Oral proteins and peptides market is projected to reach USD 7.38 billion in 2024 will increase to USD 20.36 billion by 2029, with ...
Future Market Insights1h
Rheumatic Heart Disease Management Market Set to Reach USD 2.04 Billion by 2033 at a 4.5% of CAGR
Rheumatic heart disease is a serious complication resulting from rheumatic fever, which primarily affects children and young ...
The Pharma Letter2h
New gene therapy could provide two-eye option for wet AMD
Regenxbio and AbbVie announced positive Phase II results for gene therapy ABBV-RGX-314 in wet AMD, showing a 97% reduction in ...
AbbVie: Strong Dividends But Humira Disappoints
Valuation metrics show AbbVie to be only slightly undervalued based on FY 2025 projections. Read why I'm neutral on ABBV ...
The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi
Chicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...
Zawya6h
CRISP Program, a new step by AbbVie to foster scientific expertise in the Middle East and Africa region
AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...
Taiwan News14h
Biotech Ingredients Market Emerging Trends, Applications, and Growth Projections from 2024 to 2032
Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to 2032. Request To Download Free ...
Global Antibody-Drug Conjugate Market Set for a ~USD 26 Billion Surge by 2030 | DelveInsight
DelveInsight's Antibody-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...
Yahoo Finance18h
AI driving market transformation, STD Testing Market projected to grow by USD 32.37 billion from 2024-2028 due to rising STD prevalence - Technavio
NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global sexually transmitted disease ...
PipelineReview.com22h
REGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024
ROCKVILLE, MD, USA I October 21, 2024 I REGENXBIO Inc. (Nasdaq: RGNX) today announced positive data from the Phase II fellow eye sub-study evaluating the ...
PharmiWeb23h
Global Parkinson’s Disease Market Set for USD 6.7 Billion Valuation, Powered by a 5.1% CAGR, from 2024 to 2034
Parkinson’s Disease Therapeutic MarketThe Global Parkinson’s Disease Industry is poised to achieve an estimated worth of USD 5.41 Billion, reflecting a notable increase from the USD 4.82 Billion ...